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FOSRENOL FOR ENHANCING DIETARY PROTEIN INTAKE IN
HYPOALBUMINEMIC DIALYSIS PATIENTS (FREDI) STUDY
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Manoch Rattanasompattikul, Parta Hatamizadeh, Anuja Shah, Miklos
Z Molnar, Claudia Luna, Amanda Luna, Myra Gomez, Jennie Jing,
Debbie Benner, Rajnish Mehrotra, Joel D Kopple, Kamyar Kalantar-Zadeh
Harold Simmons Center, HUMC, Torrance, CA; DaVita, Denver, CO
Protein-energy wasting (PEW), reﬂected by serum albumin o4.0 g/dL, is
common in maintenance hemodialysis (MHD) patients (pts) and is associated
with poor outcomes.
Hyperphosphatemia (phosphorus 45.5 mg/dL) is also common and is
associated with high death risk. The traditional dietary approach to control
hyperphosphatemia by limiting protein foods may cause or worsen PEW. We
hypothesized that provision of a high protein diet including during HD
treatment results in favorable outcomes if a potent phosphorus binder such as
lanthanum carbonate (FosrenolTM) can control phosphorus simultaneously and
conducted a pilot/feasibility randomized controlled trial in 110
hypoalbuminemic (o4.0 mg/dL) MHD patients in several dialysis clinics. After
a washout period and upon 1:1 randomization, we provided the
INTERVENTION group with 8 weeks of high protein meals as prepared meal
boxes (50 g protein, 850 Cal, phosphorus to protein ratio o10mg/gm) during
each HD treatment, along with 0.5 to 1.5 g Fosrenol (titrated as needed) plus
dietary counseling to maintain a high dietary protein intake at home. The
CONTROL group received meal boxes containing low calorie (o50 Cal) and
almost no protein (o1 g, such as salads) during each HD treatment and
continued non-Fosrenol binders. We examined combined change in serum
albumin with remaining in target phosphorus range of 3.5-o5.5 mg/dL over
the 8 weeks of intervention. Among the 51 intervention and 55 control subjects
who qualiﬁed for the intention-to-treat analyses, the combined rise in albumin
Z0.2 g/dL while maintaining phosphorus in 3.5-o5.5 mg/dL range was
achieved in 25.5% and 9.8%, respectively (w2 p-value 0.036). No serious adverse
events were reported, and patients reported satisfaction with high protein
meals during HD. Hence, provision of high protein meals combined with
FosrenolTM during HD is safe and may improve albumin while controlling
serum phosphorus. ClinicalTrials.gov # NCT0111694
http://dx.doi.org/10.1016/j.krcp.2012.04.527
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HAND GRIP STRENGTH AS A NUTRITIONAL MARKER IN PD AND
HEMODIALYSIS PATIENTS
Yuvaram N.V. Reddy, Laskmi Revathi S, Thiyagaraja Thandavan,
T Jayaseelan, Milly Mathew, Georgi Abraham
Madras Medical Mission Hospital, Chennai
This is a prospective study evaluating hand grip strength as a nutritional
marker in maintenance dialysis patients. Thirty CAPD and 50 MHD patients
were assessed for hand grip strength (in the non-ﬁstula arm) and demographic
variables. In the MHD, 60% diabetic and in PD 66.7% were diabetic. In the MHD
patients, Mean Age - 53.62712.45, 78% Males and 22% Females, Hb-
9.771.1 g/dL and 3.8672.83 years on dialysis and in PD patients, mean age -
58.6711.52 , 63.3% males and 26.7% females, Hb – 10.571.4 g/dL and
3.3372.6 mean years on dialysis. Hand Grip Strength was 11.58þ3.7 kg pre-
dialysis and 9.2þ3.6 kg post dialysis in MHD and 10.8þ2.9 kg in PD patients.
We found that malnutrition was present in 90% of MHD (10% severe, 24%
moderate, 56% mild) and 100% (6.7% severe, 40% moderate, 53.3% mild) of PD
patients via hand grip comparison. In conclusion, hand grip strength is a simple
tool to measure the muscle mass as a measure of malnutrition in dialysis
patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.528
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RETROSPECTIVE ANALYSIS OF PATIENT SURVIVAL BASED ON
NUTRITIONAL STATUS IN A COHORT OF HEMODIALYSIS PATIENTS FROM
TWO LARGE CENTERS IN A METROPOLITAN CITY IN A
DEVELOPING COUNTRY
Yuvaram N V Reddy, Georgi Abraham, Yogesh N V Reddy,
Prethivee Nagarajan, Milly Matthew, T. Jayaseelan, Padma G
Madras Medical Mission Hospital, Chennai
This is a retrospective analysis of 858 patients from 2 medical centers on
maintenance hemodialysis from January 1998 - January 2010(Males–599,
females 259) (364 diabetics [42.5%]) (Mean Age - 48.5þ22.74, 460 - 76.5%
and o60 – 23.5%) (Vegetarians – 18.25%, Non-Vegetarians–81.75%).
Patients were followed up for 3 years. Demographic, nutritional and renal
parameters were documented. Mean albumin - 3.47þ0.67 g/dL, mean Hb -
8.56þ5.75 g/L, Serum calcium (corrected) - 8.6þ0.9 mg/dL, serum
phosphorus - 5.32þ1.85 mg/dL, mean Ca*Po4 product - 43.27þ17.62 mg2/
dL2, mean iPTH - 260.3þ295.3pg/mL, 25-OH D3 - 23.3þ20.2 mg/dL.
Overall, 191 patients died (22%) with an 86% and 78% patient survival at
1 year and 3 years.
Age Hb
(g/L)
Cor Ca.
(mg/dL)
Albumin
(g/L)
Ca*PO4
(mg/dL)
25-OH D3
(mg/dL)
Z60 9.077.9 8.670.9 3.570.6 42.6716.7 22.9718.7
o60 8.474.7 8.471.1 3.670.5 45.3720 24.5724.8
p value .550 .2660 .396 .235 .687
There is no statistically signiﬁcant association between age, albumin levels,
vegetarianism with mortality.
http://dx.doi.org/10.1016/j.krcp.2012.04.529
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NUTRITIONAL ASSESSMENT OF CAPD PATIENTS
Hong Ren, Jingyuan Xie, Xiao Li, Xiaomin Huang, Chunyan Zhang, Nan Chen
Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School
of Medicine, 200025, Shanghai, P.R.China
Appearance and progressive development of malnutrition signiﬁcantly
inﬂuence the efﬁcacy and treatment outcome in chronic renal failure (CRF)
patients receiving continuous ambulatory peritoneal dialysis (CAPD) therapy.
The aim of the present investigation was estimation of incidence and risk
factors of the malnutrition development in CRF patients treated with CAPD.
Nutritional status was studied in 244 PD patients (97 women, 146 men; age
59.58716.55 years) being under CAPD during 1-104 (median 30) months.
Anthropometric (body mass index, dermato-fatty fold over 3-headed muscle,
Subjective Global Assessment SGA, normalized protein catabolic rate nPCR) and
biochemical indices (hemoglobin Hb, serum albumin SALB, serum pre-albumin
Spre-ALB, serum cholesterol SChol) were used for nutritional status estimation.
The overall mean body mass index was 28.18747.11. The mean level of
hemoglobin was 101.30723.81 g/L, Scr was 857.287336.17 umol/L, KT/V was
2.2570.73. The overall mean SALB was 30.6775.58 g/L, 74.2% patients on low
SALB (SALB o35 g/L). The mean level of Spre-ALB was 331.63791.43 mg/L,
35.66% patients on low Spre-ALB (Spre-ALB o300 mg/L). The mean level of
PCR was 0.9370.24 g/kg.d, 59.01% patients on low level PCR (PCR o1 g/kg.d).
The mean dermato-fatty fold over 3-headed muscle was 13.42 mm. 25%
patients had a SGA score of 1-4(malnutrition range). The prevalence of
malnutrition was 18.03%. The main cause (44.6%) of death is infection in our
study, and the majority of these patients were complicated with different level
of malnutrition. In conclusion, the results indicate that malnutrition is quite
common and plays an important role in mortality in CAPD patients
independent of dialysis efﬁcacy and prevention or treatment of malnutrition by
suitable means is necessary to improve clinical outcomes in CAPD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.530
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EFFECTS OF 12 WEEKS NUTRITION EDUCATION ON NUTRITIONAL
STATUS IN HEMODIALYSIS PATIENTS
Harin Rhee, KeumSook Jang, Sang Heon Song, Il Young Kim, Eun Young
Seong, Soo Bong Lee, M.D IhmSooKwak
Division of Nephrology, Pusan National University Hospital,Republic of Korea
Protein-energy malnutrition is present in a large proportion of patients with
end stage renal disease and, is a strong risk factor for mortality in these
patients. This study was aimed to evaluate the effectiveness of 12-weeks
nutrition education during the hemodialysis session for the improvement of
nutritional status. From the June 2011 to the September 2011, patients who
were on regular hemodialysis in Pusan National University Hospital were
enrolled in this study. In education group, intensive nutrition education was
performed by the hemodialysis nurse, for ﬁfty to sixty minutes during the
hemodialysis session, once a week. Curriculum for renal nutrition includes
regular taking of their medication, intake of moderate amount of protein and
Kidney Res Clin Pract 31 (2012) A16–A96A68
